The unique physical properties of optical coherence tomography (OCT) make it a useful technique in the study of restenosis mechanisms. In fact, OCT is able to differentiate between neointimal proliferation and neoatherosclerosis within the stent. We report a rare case of occlusive neoatherosclerosis presenting beyond one year after a successful drug-eluting stent implantation. The impact of OCT findings in the clinical decision making process is emphasized.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.carrev.2016.09.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association Between the Neutrophil-to-Lymphocyte Ratio and in-Stent Neoatherosclerosis and Plaque Vulnerability: An Optical Coherence Tomography Study.
J Cardiovasc Pharmacol
November 2024
Department of Cardiology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
The aim of this study was to explore the relationship between in-stent neoatherosclerosis (ISNA) and the neutrophil-to-lymphocyte ratio (NLR) in patients with in-stent restenosis (ISR) following drug-eluting stent (DES) implantation. We divided 216 patients into 3 groups based on the NLR tertile. We performed a comparative analysis of baseline, angiographic, and features of optical coherence tomography (OCT) between the NLR groups and performed univariate and multivariate logistic regression analyses to assess the association of the NLR with ISNA and in-stent thin-cap fibroatheroma (TCFA).
View Article and Find Full Text PDFStent Underexpansion Is an Underestimated Cause of Intrastent Restenosis: Insights From RESTO Registry.
J Am Heart Assoc
November 2024
Institut Cardiovasculaire Paris Sud Massy France.
Background: Despite improvement in devices, in-stent restenosis remains a frequent and challenging complication of percutaneous coronary interventions.
Methods And Results: The RESTO (Morphological Parameters of In-Stent Restenosis Assessed and Identified by OCT [Optical Coherence Tomography]; study NCT04268875) was a prospective multicenter registry including patients presenting with coronary syndromes related to in-stent restenosis. All patients underwent preintervention OCT analysis, which led to analysis of in-stent restenosis phenotype, number of strut layers, and presence of stent underexpansion.
Successful intravascular lithotripsy after all other options failed with stent under-expansion: a case report and review of alternative options.
Eur Heart J Case Rep
October 2024
GRN Hospital Weinheim, Department of Cardiology, Vascular Medicine & Pneumology, Röntgenstraße 1, 69469 Weinheim, Germany.
Article Synopsis
- Stent under-expansion can increase risks like neoatherosclerosis and stent thrombosis, especially in cases of severe coronary calcification, and intravascular lithotripsy (IVL) can help prevent this by ensuring proper stent expansion.
- A 62-year-old male with unstable angina was treated for high-grade stenosis in the right coronary artery but experienced stent under-expansion despite multiple attempts to dilate it, including using ultra-high-pressure balloons.
- The successful use of IVL led to complete stent expansion at a lower pressure, illustrating its effectiveness and safety in treating stent under-expansion, which is critical for preventing complications like restenosis and thrombosis.
Systemic immune inflammation index is associated with in-stent neoatherosclerosis and plaque vulnerability: An optical coherence tomography study.
Heliyon
August 2024
Department of Cardiology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Background: In-stent neoatherosclerosis (ISNA) is identified as the primary cause of in-stent restenosis (ISR). The systemic immune inflammation index (SII), shows promise for predicting post-percutaneous coronary intervention (PCI) adverse cardiovascular events and is associated with coronary stenosis severity; however, its specific relationship with ISNA remains unclear. This study aimed to investigate the association between the SII and ISNA after drug-eluting stent (DES) implantation.
View Article and Find Full Text PDFLong-term effect of biodegradable vs durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial.
Eur Heart J
September 2024
Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
Article Synopsis
- Neoatherosclerosis is a major cause of late stent failure after drug-eluting stent implantation, and the study aimed to compare biodegradable (BP) and durable polymer (DP) drug-eluting stents in patients with STEMI over a 3-year period.
- The CONNECT trial randomly assigned 239 STEMI patients to receive either BP-EES or DP-EES, with the primary goal of assessing neoatherosclerosis using optical coherence tomography (OCT) at the 3-year mark.
- Results showed no significant difference in the occurrence of neoatherosclerosis or other complications between the two stent types, indicating that BP-EES did not perform better than DP-EES in preventing neoatherosclerosis after
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!